表紙SALE
市場調查報告書
商品編碼
998646

全球出血性疾病治療市場:按藥物類型,疾病類型,分銷渠道,性別,最終用戶和地區劃分的競爭性預測和市場機會(2026)

Global Bleeding Disorders Drugs Market, By Drug Type (Plasma-derived Coagulation Factor Concentrates, Others), Disease Type, Distribution Channel, Gender , End User, Region, Competition Forecast & Opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

到2026年,全球出血性疾病市場將繼續以8.44%的複合年增長率增長,到2026年預計將達到24,078,160,000美元。

市場的主要推動力是世界範圍內血液病患者的數量不斷增加,以及對改善治療可用性的需求不斷增長。按藥物類型,重組凝血因子濃縮物佔有52.91%的份額。按疾病的類型,血友病A是最常見的,並且是市場上的推動力。按地區劃分,雖然北美國家占主導地位,但預計亞太國家也將經歷快速的市場增長。

本報告分析了出血性疾病治療藥物的全球市場,並預測了整體市場規模和份額結構(按藥物類型,疾病類型,分銷渠道,性別和最終用途)(按用戶),詳細趨勢按地區/主要國家/地區,主要市場促進/限制因素,公司之間的市場競爭結構,主要公司的概況,市場增長的未來方向等。

目錄

第1章產品概述

第2章分析方法

第3章冠狀病毒感染(COVID-19):對全球出血性疾病治療市場的影響

第4章執行摘要

第5章客戶視圖

  • 品牌知名度
  • 患者滿意度
  • 推動全球出血性疾病市場發展的因素

第6章全球出血性疾病治療市場:未來前景

  • 市場規模及其預測
    • 金額基數
  • 市場份額及其預測
    • 按藥物類型(血漿來源的凝血因子濃縮物,重組凝血因子濃縮物,去氨加壓素,抗纖溶藥物,血纖蛋白封閉劑等)
    • 按疾病類型(A型血友病,B型血友病,von Willebrand病等)
    • 通過分銷渠道(醫院藥房,零售藥房,在線)
    • 按性別(男性/女性)
    • 最終用戶(醫院,血友病治療中心,研究所等)
    • 按公司劃分(2020)
    • 按地區(北美,歐洲,亞太地區,南美,中東/非洲)
  • 產品市場圖

第7章北美出血病治療市場:未來前景

  • 市場規模及其預測
  • 市場份額及其預測
  • 北美:國家分析
    • 美國市場
    • 加拿大市場
    • 墨西哥市場

第8章歐洲出血性疾病治療市場:未來前景

  • 市場規模及其預測
  • 市場份額及其預測
  • 歐洲:國家分析
    • 德國市場
    • 英國市場
    • 法國市場
    • 意大利市場
    • 西班牙市場

第9章亞太地區出血性疾病治療市場:未來前景

  • 市場規模及其預測
  • 市場份額及其預測
  • 亞太地區:國家分析
    • 印度市場
    • 中國市場
    • 日本市場
    • 澳大利亞市場
    • 韓國市場

第10章南美出血病治療市場:未來前景

  • 市場規模及其預測
  • 市場份額及其預測
  • 南美:國家分析
    • 巴西市場
    • 阿根廷市場
    • 哥倫比亞市場

第11章中東/非洲出血病治療市場:未來前景

  • 市場規模及其預測
  • 市場份額及其預測
  • 中東/非洲:國家分析
    • 沙特阿拉伯市場
    • 阿拉伯聯合酋長國(UAE)市場
    • 南非市場

第12章市場動態

  • 促進因素
  • 挑戰

第13章市場趨勢

第14章競爭情況

  • 市場競爭前景
  • 分析目標公司(主要公司)
    • Bayer AG
    • Pfizer Inc.
    • Grifols S.A.
    • Octapharma AG
    • Ferring Pharmaceuticals SA
    • Sanofi SA
    • Baxter International Inc.
    • F. Hoffmann-La Roche Ltd.
    • Takeda Pharmaceuticals Ltd.
    • Novo Nordisk A/S
    • Novartis AG
    • CSL Limited
    • Teva Pharmaceutical Industries Ltd.
    • Cadila Healthcare Ltd
    • Johnson & Johnson International Inc.

第15章戰略建議

第16章TechSci Research的免責聲明

目錄
Product Code: 7331

Global Bleeding Disorders Drugs Market is expected to grow at robust rate with a CAGR of 8.44% in value terms to reach USD24078.16 million by 2026 on account of increasing concerns for blood disorders among the worldwide population. Rising cases of bleeding disorders across the globe is a major driving force for the Global Bleeding Disorders Drugs Market in the forecast period, 2022-2026F. Moreover, increasing awareness towards the growing patient count and availability of treatment methods will support the growth of Global Bleeding Disorders Drugs Market, positively.

Global Bleeding Disorders Drugs Market is segmented by drug type, disease type, distribution channel, gender, end user, and regional distribution. Based on disease type the market is further fragmented into Hemophilia A, Hemophilia B, Von Willebrand Disease, and others. Hemophilia A disease is the most common among the disease type and thus drives Global Bleeding Disorders Drugs market.

The drug type segment has been further segregated into Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants and Others. The Recombinant Coagulation Factor Concentrates dominated the overall market with 52.91% market share in 2020. The Region segment is fragmented into North America, Asia-Pacific, Europe, South America and Middle East and Africa. North America is expected to dominate the market whereas Asia-Pacific is projected to be the fastest leading region in the forecast period.

Some of the major competitors in the market are Bayer AG, Grifols S.A., Pfizer Inc., Octapharma AG, Ferring Pharmaceuticals SA, Sanofi SA, Baxter International Inc., F. Hoffmann-La Roche Ltd., Takeda Pharmaceuticals Ltd., Novo Nordisk A/S, Novartis AG, CSL Limited, Teva Pharmaceutical Industries Ltd., Cadila Healthcare Ltd. and Johnson & Johnson International, Inc. The companies are focusing on extensive research and developments activities to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships.

Years considered for this report:

Historical Years: 2016 - 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 - 2026

Objective of the Study:

  • To analyze historical growth in market size of Global Bleeding Disorders Drugs Market from 2016 to 2020.
  • To estimate and forecast the market size of Global Bleeding Disorders Drugs Market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast Global Bleeding Disorders Drugs Market based on drug type, disease type, distribution channel, end user, and regional distribution.
  • To identify dominant region or segment in the Global Bleeding Disorders Drugs Market.
  • To identify drivers and challenges for Global Bleeding Disorders Drugs Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Global Bleeding Disorders Drugs Market.
  • To identify and analyze the profiles of leading players operating in Global Bleeding Disorders Drugs Market.
  • To identify key sustainable strategies adopted by market players in Global Bleeding Disorders Drugs Market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of Global Bleeding Disorders Drugs Market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated them through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Bleeding disorders treatment drugs vendors, end users, service providers and other stakeholders
  • Distributers and suppliers of bleeding disorders treatment products and services and other stakeholders
  • Organizations, forums, and alliances related to bleeding disorders treatment
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Global Bleeding Disorders Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Bleeding Disorders Drugs Market, By Drug Type:

Plasma-derived Coagulation Factor Concentrates

Recombinant Coagulation Factor Concentrates

Desmopressin

Antifibrinolytics

Fibrin Sealants

Others

  • Global Bleeding Disorders Drugs Market, By Disease Type:

Hemophilia A

Hemophilia B

Von Willebrand Disease

Others

  • Global Bleeding Disorders Drugs Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online

  • Global Bleeding Disorders Drugs Market, By Gender

Male

Female

  • Global Bleeding Disorders Drugs Market, By End User:

Hospitals

Hemophilia Treatment Centers

Research Institutes

Others

  • Global Bleeding Disorders Drugs Market, By Region:

North America

APAC

Europe

South America

MEA

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Bleeding Disorders Drugs Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Bleeding Disorders Drugs Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. Patients Satisfaction
  • 5.3. Factors driving the global bleeding disorder market

6. Global Bleeding Disorders Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others)
    • 6.2.2. By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others)
    • 6.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online)
    • 6.2.4. By Gender (Male v/s Female)
    • 6.2.5. By End User (Hospitals, Hemophilia Treatment Centers, Research Institutes, Others)
    • 6.2.6. By Company (2020)
  • 6.3. Product Market Map

7. North America Bleeding Disorders Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Type
    • 7.2.2. By Disease Type
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Gender
    • 7.2.5. By End User
    • 7.2.6. By Country (United States; Canada; Mexico)
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Bleeding Disorders Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Type
        • 7.3.1.2.2. By Disease Type
        • 7.3.1.2.3. By Distribution Channel
        • 7.3.1.2.4. By Gender
        • 7.3.1.2.5. By End User
    • 7.3.2. Canada Bleeding Disorders Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Type
        • 7.3.2.2.2. By Disease Type
        • 7.3.2.2.3. By Distribution Channel
        • 7.3.2.2.4. By Gender
        • 7.3.2.2.5. By End User
    • 7.3.3. Mexico Bleeding Disorders Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Type
        • 7.3.3.2.2. By Disease Type
        • 7.3.3.2.3. By Distribution Channel
        • 7.3.3.2.4. By Gender
        • 7.3.3.2.5. By End User

8. Europe Bleeding Disorders Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Type
    • 8.2.2. By Disease Type
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Gender
    • 8.2.5. By End User
    • 8.2.6. By Country (Germany; United Kingdom; France; Italy; Spain)
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Bleeding Disorders Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Type
        • 8.3.1.2.2. By Disease Type
        • 8.3.1.2.3. By Distribution Channel
        • 8.3.1.2.4. By Gender
        • 8.3.1.2.5. By End User
    • 8.3.2. United Kingdom Bleeding Disorders Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Type
        • 8.3.2.2.2. By Disease Type
        • 8.3.2.2.3. By Distribution Channel
        • 8.3.2.2.4. By Gender
        • 8.3.2.2.5. By End User
    • 8.3.3. France Bleeding Disorders Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Type
        • 8.3.3.2.2. By Disease Type
        • 8.3.3.2.3. By Distribution Channel
        • 8.3.3.2.4. By Gender
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Bleeding Disorders Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Drug Type
        • 8.3.4.2.2. By Disease Type
        • 8.3.4.2.3. By Distribution Channel
        • 8.3.4.2.4. By Gender
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Bleeding Disorders Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Drug Type
        • 8.3.5.2.2. By Disease Type
        • 8.3.5.2.3. By Distribution Channel
        • 8.3.5.2.4. By Gender
        • 8.3.5.2.5. By End User

9. Asia Pacific Bleeding Disorders Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Type
    • 9.2.2. By Disease Type
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Gender
    • 9.2.5. By End User
    • 9.2.6. By Country (India; China; Japan; Australia; South Korea)
  • 9.3. Asia Pacific: Country Analysis
    • 9.3.1. India Bleeding Disorders Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Type
        • 9.3.1.2.2. By Disease Type
        • 9.3.1.2.3. By Distribution Channel
        • 9.3.1.2.4. By Gender
        • 9.3.1.2.5. By End User
    • 9.3.2. China Bleeding Disorders Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Type
        • 9.3.2.2.2. By Disease Type
        • 9.3.2.2.3. By Distribution Channel
        • 9.3.2.2.4. By Gender
        • 9.3.2.2.5. By End User
    • 9.3.3. Japan Bleeding Disorders Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Type
        • 9.3.3.2.2. By Disease Type
        • 9.3.3.2.3. By Distribution Channel
        • 9.3.3.2.4. By Gender
        • 9.3.3.2.5. By End User
    • 9.3.4. Australia Bleeding Disorders Drugs Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Drug Type
        • 9.3.4.2.2. By Disease Type
        • 9.3.4.2.3. By Distribution Channel
        • 9.3.4.2.4. By Gender
        • 9.3.4.2.5. By End User
    • 9.3.5. South Korea Bleeding Disorders Drugs Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Drug Type
        • 9.3.5.2.2. By Disease Type
        • 9.3.5.2.3. By Distribution Channel
        • 9.3.5.2.4. By Gender
        • 9.3.5.2.5. By End User

10. South America Bleeding Disorders Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Type
    • 10.2.2. By Disease Type
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Gender
    • 10.2.5. By End User
    • 10.2.6. By Country (Brazil; Argentina; Colombia)
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bleeding Disorders Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Type
        • 10.3.1.2.2. By Disease Type
        • 10.3.1.2.3. By Distribution Channel
        • 10.3.1.2.4. By Gender
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Bleeding Disorders Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Type
        • 10.3.2.2.2. By Disease Type
        • 10.3.2.2.3. By Distribution Channel
        • 10.3.2.2.4. By Gender
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Bleeding Disorders Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Type
        • 10.3.3.2.2. By Disease Type
        • 10.3.3.2.3. By Distribution Channel
        • 10.3.3.2.4. By Gender
        • 10.3.3.2.5. By End User

11. Middle East & Africa Bleeding Disorders Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Drug Type
    • 11.2.2. By Disease Type
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Gender
    • 11.2.5. By End User
    • 11.2.6. By Country (UAE; Saudi Arabia; South Africa)
  • 11.3. Middle East & Africa: Country Analysis
    • 11.3.1. Saudi Arabia Bleeding Disorders Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Drug Type
        • 11.3.1.2.2. By Disease Type
        • 11.3.1.2.3. By Distribution Channel
        • 11.3.1.2.4. By Gender
        • 11.3.1.2.5. By End User
    • 11.3.2. UAE Bleeding Disorders Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Drug Type
        • 11.3.2.2.2. By Disease Type
        • 11.3.2.2.3. By Distribution Channel
        • 11.3.2.2.4. By Gender
        • 11.3.2.2.5. By End User
    • 11.3.3. South Africa Bleeding Disorders Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Drug Type
        • 11.3.3.2.2. By Disease Type
        • 11.3.3.2.3. By Distribution Channel
        • 11.3.3.2.4. By Gender
        • 11.3.3.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Global Players Profiled (Leading Companies)
    • 14.2.1. Bayer AG
    • 14.2.2. Pfizer Inc.
    • 14.2.3. Grifols S.A.
    • 14.2.4. Octapharma AG
    • 14.2.5. Ferring Pharmaceuticals SA
    • 14.2.6. Sanofi SA
    • 14.2.7. Baxter International Inc.
    • 14.2.8. F. Hoffmann-La Roche Ltd.
    • 14.2.9. Takeda Pharmaceuticals Ltd.
    • 14.2.10. Novo Nordisk A/S
    • 14.2.11. Novartis AG
    • 14.2.12. CSL Limited
    • 14.2.13. Teva Pharmaceutical Industries Ltd.
    • 14.2.14. Cadila Healthcare Ltd
    • 14.2.15. Johnson & Johnson International Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 2: Global Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 3: Global Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 4: Global Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 5: Global Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 6: Global Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 7: Global Bleeding Disorders Drugs Market, Market Map, By Region, By Value, 2016-2026F
  • Figure 8: North America Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 9: North America Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 10: North America Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 11: North America Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 12: North America Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 13: North America Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 14: United States Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 15: United States Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 16: United States Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 17: United States Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 18: United States Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 19: United States Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 20: Canada Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 21: Canada Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 22: Canada Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 23: Canada Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 24: Canada Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 25: Canada Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 26: Mexico Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 27: Mexico Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 28: Mexico Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 29: Mexico Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 30: Mexico Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 31: Mexico Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 32: Europe Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 33: Europe Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 34: Europe Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 35: Europe Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 36: Europe Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 37: Europe Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 38: Germany Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 39: Germany Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 40: Germany Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 41: Germany Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 42: Germany Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 43: Germany Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 44: United Kingdom Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 45: United Kingdom Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 46: United Kingdom Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 47: United Kingdom Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 48: United Kingdom Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 49: United Kingdom Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 50: France Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 51: France Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 52: France Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 53: France Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 54: France Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 55: France Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 56: Italy Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 57: Italy Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 58: Italy Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 59: Italy Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 60: Italy Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 61: Italy Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 62: Spain Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 63: Spain Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 64: Spain Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 65: Spain Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 66: Spain Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 67: Spain Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 68: Asia Pacific Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 69: Asia Pacific Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 70: Asia Pacific Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 71: Asia Pacific Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 72: Asia Pacific Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 73: Asia Pacific Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 74: India Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 75: India Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 76: India Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 77: India Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 78: India Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 79: India Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 80: China Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 81: China Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 82: China Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 83: China Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 84: China Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 85: China Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 86: Japan Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 87: Japan Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 88: Japan Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 89: Japan Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 90: Japan Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 91: Japan Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 92: Australia Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 93: Australia Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 94: Australia Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 95: Australia Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 96: Australia Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 97: Australia Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 98: South Korea Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 99: South Korea Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 100: South Korea Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 101: South Korea Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 102: South Korea Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 103: South Korea Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 104: South America Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 105: South America Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 106: South America Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 107: South America Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 108: South America Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 109: South America Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 110: Brazil Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 111: Brazil Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 112: Brazil Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 113: Brazil Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 114: Brazil Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 115: Brazil Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 116: Argentina Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 117: Argentina Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 118: Argentina Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 119: Argentina Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 120: Argentina Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 121: Argentina Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 122: Colombia Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 123: Colombia Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 124: Colombia Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 125: Colombia Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 126: Colombia Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 127: Colombia Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 128: Middle East and Africa Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 129: Middle East and Africa Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 130: Middle East and Africa Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 131: Middle East and Africa Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 132: Middle East and Africa Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 133: Middle East and Africa Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 134: Saudi Arabia Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 135: Saudi Arabia Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 136: Saudi Arabia Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 137: Saudi Arabia Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 138: Saudi Arabia Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 139: Saudi Arabia Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 140: UAE Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 141: UAE Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 142: UAE Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 143: UAE Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 144: UAE Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 145: UAE Bleeding Disorders Drugs Market Share, By End User, 2016-2026F
  • Figure 146: South Africa Bleeding Disorders Drugs Market Size, By Value (USD Million), 2016-2026F
  • Figure 147: South Africa Bleeding Disorders Drugs Market Share, By Drug Type, 2016-2026F
  • Figure 148: South Africa Bleeding Disorders Drugs Market Share, By Disease Type, 2016-2026F
  • Figure 149: South Africa Bleeding Disorders Drugs Market Share, By Distribution Channel, 2016-2026F
  • Figure 150: South Africa Bleeding Disorders Drugs Market Share, By Gender, 2016-2026F
  • Figure 151: South Africa Bleeding Disorders Drugs Market Share, By End User, 2016-2026F